FDA Skin-Renew coverage for business development, investment, and market access teams
The FDA has granted approval for Skin-Renew, a groundbreaking treatment for severe eczema, providing patients with a new option for managing their condition.
We use cookies to enhance your experience, analyze traffic, and for marketing. By continuing to use our site, you consent to our use of cookies. Privacy Policy
